GAfPA Blog

The GAfPA Patient Advocacy Blog

What Heart Attack & Stroke Mean to EU Workplaces

Heart attack and stroke don’t just affect patients across Europe, new research reveals.  These cardiovascular events also impact the EU’s national economies – by increasing absenteeism and reducing productivity in workplaces across the region. Productivity Loss & Economic Impact Among patients who returned to work, having a heart attack or stroke was associated with losing … Continued

What EU Parliamentary Candidates Need to Know about Heart Health

As the European Union edges toward parliamentary elections, patient advocates have a message for candidates: Prioritise heart health. As outlined in a recently released manifesto from the European Heart Network, a Brussels-based alliance of foundations and associations dedicated to fighting heart disease and stroke, Members of the European Parliament have the opportunity to support investment … Continued

New “Fast Facts” Highlights Impact of High Cholesterol on Europe

More than 50 percent of Europeans have raised cholesterol, increasing their risk of heart attack, stroke and death – and costing the EU billions every year in health care expenses and lost productivity.  So explains a new “Fast Facts” policy brief from the European Alliance for Patient Access, a division of the Global Alliance for … Continued

England Sets Sights on Heart Health

England has a plan.  It’s comprehensive, long term and aimed at preventing 150,000 heart attacks and strokes over the next 10 years.  How? By, among other measures, reducing high cholesterol, hypertension and atrial fibrillation. Recently released by the National Health Service, England’s “Long-Term Plan” outlines national health strategies for a variety of national health needs … Continued

GAfPA’s Statement Supporting the USMCA Signing at the G20 Summit

A new international treaty has important implications for patients’ access to innovative treatments. On November 30, during the G20 Summit in Buenos Aires Argentina, President Trump, Prime Minister Trudeau and President Peña Nieto signed the new U.S. Mexico Canada Agreement. Once approved by the U.S. Congress, this trade deal will replace NAFTA as the free … Continued

GAfPA Statement on United States-Mexico-Canada Agreement

Patients who are eager for the next generation of treatments and cures will be well served by the United States-Mexico-Canada Agreement.  This agreement provides intellectual property protections that promote patient access to innovative medicine, clearing the way for new treatments for cancer, Alzheimer’s, diabetes and many other conditions.

La farmacovigilancia como modo de reforzamiento de regulaciones

  El viernes 24 de agosto de 2018 se llevó a cabo el primer webinario de la Academia Latinoamericana de Pacientes. La academia tuvo su primera reunión en la ciudad de Miami el 26 de mayo. Este webinario sirvió como un seguimiento de esa reunión. El tema del webinario enfocaba en la farmacovigilancia como modo … Continued

How Latin America Can Avoid a Health Care Misstep

When public health emergencies threaten developing nations, governments may look for cheap, fast ways to secure necessary medicine.  One option is compulsory licensing, the topic of a new “Fast Facts” from the Global Alliance for Patient Access. But how does compulsory licensing work?  And does it really meet patients’ needs? Compulsory licensing occurs when governments … Continued

School’s in Session at the Latin American Patient Academy

Patient advocates from Latin America are about to get schooled – in the best possible way. The first collaborative education program for advocacy leaders, Miami’s Latin American Patient Academy, now offers the only program of its kind in the world. The academy allows advocacy organizations to strengthen their leaders in three areas: Regulations Evaluation of … Continued

Sign up to receive updates from GAfPA